Pathway Choice of DNA Double-Strand Break Repair
Pathway Choice of DNA Double-Strand Break Repair
批准号:
8631070
负责人:
DAVID J CHEN
金额:
$32.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-09 至 2017-03-31
关键词:
Am 80ApoptosisAttenuatedBindingCancer BiologyCell CycleCell Cycle StageCell DeathCellsChromatinChromosome abnormalityClinicalComplexDNADNA DamageDNA Double Strand BreakDNA RepairDNA-PKcsDataDissociationDouble Strand Break RepairEnvironmentEnzymesEukaryotic CellEventExcisionFrequenciesG2 PhaseG22P1 geneGenesGenomic InstabilityGoalsHereditary DiseaseHomologous GeneHumanHuman GeneticsHuman GenomeIn VitroIncidenceIonizing radiationKu ProteinLaboratoriesLeadLigationMalignant NeoplasmsMediatingMetabolismModalityModelingMolecularMusMutationMycobacterium tuberculosisNonhomologous DNA End JoiningPathway interactionsPharmaceutical PreparationsPhasePhosphorylationPhosphorylation SitePlayProcessProtein KinaseProteinsRadiation therapyRecruitment ActivityRegulationRoleS PhaseSiteSynapsesTestingTherapeuticTherapeutic AgentsTranslatingXRCC2 genecancer cellcancer therapycarcinogenesishelicasehomologous recombinationin vivoinsightmutantneoplastic cellnovelpreventrecombinational repairrepairedsenescencetumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): DNA double strand breaks (DSBs) are caused by endogenous (byproducts of cellular metabolism and replication associated errors) and exogenous (ionizing radiation and chemotherapeutic drugs) agents. Unrepaired or misrepaired DSBs can result in senescence, inducted apoptosis, or chromosomal aberrations, including translocations and deletions. These chromosomal aberrations can lead to genomic instability and tumorigenesis. To counteract the effects of DNA DSBs, two highly efficient DSB repair pathways have evolved in eukaryotic cells: non-homologous end-joining (NHEJ) and homologous recombination (HR). The NHEJ pathway utilizes several enzymes, including Ku70/80 and DNA-PKcs, that capture both DNA ends, bring them together in a synaptic complex, and facilitate direct ligation of the DSB. HR is initiated once 5'-3' resection of the DSB
occurs. The 5'-3' resection creates ssDNA ends which are subsequently used for strand invasion and exchange into a homologous DNA template and once resolved, the DSB is fully repaired. One of the major unresolved questions in the field of DNA repair is the mechanism that modulates the pathway choice between NHEJ and HR. The goal of this proposal is to test our hypothesis that the binding of Ku70/80 to DSBs plays a key role in protecting DNA ends regardless of the cell cycle stage and that dissociation of Ku from DSBs is one of the mechanisms responsible for modulating pathway choice between NHEJ and HR. In G1, we hypothesize that Ku70/80 mediates NHEJ-mediated DSB repair, but in S/G2 phases of the cell cycle it protects DNA from non-specific end processing until it is actively displaced from DSB ends to allow DNA end resection and HRmediated DSB repair. To test this hypothesis, we propose the following specific aims: 1) To test the hypothesis that Ku70/80 is required for DNA end stability in S phase of the cell cycle. Furthermore, we will determine if Ku70/80 blocks DNA end processing by assessing its ability to block DNA end resection via the known human factors responsible for this process using model DNA substrates, including a mononucleosome chromatin substrate in vitro. 2) To further support our hypothesis that Ku70/80 must be displaced from DSB ends for DNA end resection and HR to initiate, we will test if these processes are attenuated if DSB ends are persistently occupied by Ku in vivo. 3) To determine the mechanism that modulates Ku70/80's dissociation from DSBs to allow the initiation of DNA end resection and HR in S/G2 phases of the cell cycle. Basic mechanistic insights into DSB repair mechanisms and the regulation of pathway choice for the repair of DSBs is important as DSB repair is paramount for protecting the human genome. This is supported by the observations that an increase in cancer frequency is observed in mice and humans with mutations in genes that encode proteins responsible for the repair of DSBs. Furthermore, induction of DSBs is used as a therapeutic modality for cancer treatment. Taken together, these underlie the importance of understanding the coordination and function of DSB repair and insights into repair mechanisms will ultimately translate into clinical targets and benefits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathway Choice of DNA Double-Strand Break Repair
-
批准号:8305249
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2012
-
负责人:DAVID J CHEN
-
依托单位:
Pathway Choice of DNA Double-Strand Break Repair
-
批准号:8457051
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2012
-
负责人:DAVID J CHEN
-
依托单位:
Functions of WRN in Response to DNA Double-Strand Breaks
-
批准号:8433268
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2009
-
负责人:DAVID J CHEN
-
依托单位:
Functions of WRN in Response to DNA Double-Strand Breaks
-
批准号:8215807
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2009
-
负责人:DAVID J CHEN
-
依托单位:
Functions of WRN in Response to DNA Double-Strand Breaks
-
批准号:7652143
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2009
-
负责人:DAVID J CHEN
-
依托单位:
Functions of WRN in Response to DNA Double-Strand Breaks
-
批准号:8015989
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2009
-
负责人:DAVID J CHEN
-
依托单位:
IRRADIATION INDUCED G2 & M PHASE ARREST IN SENSITIVE & RESISTANT MOUSE CELLS
-
批准号:6976457
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2004
-
负责人:DAVID J CHEN
-
依托单位:
Transgenic Mouse for DNA Damage Sensing and Signaling
-
批准号:6480292
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2002
-
负责人:DAVID J CHEN
-
依托单位:
Transgenic Mouse for DNA Damage Sensing and Signaling
-
批准号:6723699
-
项目类别:
-
资助金额:$9.74万
-
财政年份:2002
-
负责人:DAVID J CHEN
-
依托单位:
Transgenic Mouse for DNA Damage Sensing and Signaling
-
批准号:6625944
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2002
-
负责人:DAVID J CHEN
-
依托单位:
Transgenic Mouse for DNA Damage Sensing and Signaling
-
批准号:6858783
-
项目类别:
-
资助金额:$26.52万
-
财政年份:2002
-
负责人:DAVID J CHEN
-
依托单位:
Transgenic Mouse for DNA Damage Sensing and Signaling
-
批准号:6948402
-
项目类别:
-
资助金额:$20.71万
-
财政年份:2002
-
负责人:DAVID J CHEN
-
依托单位:
IRRADIATION INDUCED G2 & M PHASE ARREST IN RAD SENSITIVE & RESISTANT MOUSE CELLS
-
批准号:6470672
-
项目类别:
-
资助金额:$12.12万
-
财政年份:2001
-
负责人:DAVID J CHEN
-
依托单位:
KU, TELOMERE MAINTENANCE AND CELLULAR SENESCENCE
-
批准号:6345810
-
项目类别:
-
资助金额:$13.97万
-
财政年份:2000
-
负责人:DAVID J CHEN
-
依托单位:
KU, TELOMERE MAINTENANCE AND CELLULAR SENESCENCE
-
批准号:6532557
-
项目类别:
-
资助金额:$53.33万
-
财政年份:2000
-
负责人:DAVID J CHEN
-
依托单位:
KU, TELOMERE MAINTENANCE AND CELLULAR SENESCENCE
-
批准号:6372549
-
项目类别:
-
资助金额:$52.0万
-
财政年份:2000
-
负责人:DAVID J CHEN
-
依托单位:
KU, TELOMERE MAINTENANCE AND CELLULAR SENESCENCE
-
批准号:6050772
-
项目类别:
-
资助金额:$50.71万
-
财政年份:2000
-
负责人:DAVID J CHEN
-
依托单位:
IRRADIATION INDUCED G2 & M PHASE ARREST IN RAD SENSITIVE & RESISTANT MOUSE CELLS
-
批准号:6327965
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2000
-
负责人:DAVID J CHEN
-
依托单位:
KU, TELOMERE MAINTENANCE AND CELLULAR SENESCENCE
-
批准号:6641120
-
项目类别:
-
资助金额:$54.69万
-
财政年份:2000
-
负责人:DAVID J CHEN
-
依托单位:
KU, TELOMERE MAINTENANCE AND CELLULAR SENESCENCE
-
批准号:6980457
-
项目类别:
-
资助金额:$56.1万
-
财政年份:2000
-
负责人:DAVID J CHEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: